Introduction: Stress-induced cardiomyopathy (SIC) has a higher incidence in Caucasians (CAUCs) compared to African-Americans (AAs). Whether this is due to racial predisposition, selection bias, or environmental factors remains unclear. Hypothesis: We hypothesize that people from lower socioeconomic strata (SES) have a lower incidence of SIC. It is possible that the incidence of SIC could be similar among CAUCs and AAs at the same SES. Stress preconditioning maybe protective in preventing SIC. Methods: Data of patients with the discharge diagnosis of SIC were extracted from the Myocardial Infarction Data Acquisition System spanning the period from 2006 through 2015. The incidence of SIC among CAUCs and AAs was compared per 100,000 New Jersey population and examined across income brackets. CAUCs and AAs data were compared using two-sample proportion tests. Results: During the study period, CAUCs had an overall higher incidence of SIC compared to AAs, 0.017% versus 0.0084% per 100,000 population (p value <0.0001). This difference persisted after a logistic regression adjustment (p = 0.0064). CAUCs in the income brackets of 30–40k had lower incidence of SIC than those in the 60–80k income bracket (p = 0.0156). Those with an income of 60–80k had lower incidence of SIC compared to those with an income of 80–100k. AAs with income between 30 and 60k had a lower incidence of SIC than CAUCs (p = 0.0330). Conclusions: CAUCs exhibited a trend towards less SIC as a function of lower income. This was not observed among AAs. AAs had a lower incidence of SIC. Our study suggests that SES has a protective effect among CAUCs.

1.
Dias
A
,
Franco
E
,
Koshkelashvili
N
,
Pressman
GS
,
Hebert
K
,
Figueredo
VM
.
Racial and ethnic differences in Takotsubo cardiomyopathy presentation and outcomes
.
Int J Cardiol
.
2015
;
194
:
100
3
. .
2.
Pizzino
G
,
Bitto
A
,
CreaKhandheria
PB
,
Vriz
O
,
Carerj
S
,
Squadrito
F
,
Takatsubo syndrome and estrogen receptor genes: partners in crime?
J Cardiovasc Med
.
2017
;
18
:
268
76
.
3.
Pezzo
SP
,
Hartlage
G
,
Edwards
CM
.
Takotsubo cardiomyopathy presenting with dyspnea
.
J Hosp Med
.
2009
;
4
(
3
):
200
2
. .
4.
Gianni
M
,
Dentali
F
,
Grandi
AM
,
Sumner
G
,
Hiralal
R
,
Lonn
E
.
Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review
.
Eur Heart J
.
2006
;
27
(
13
):
1523
9
. .
5.
Vriz
O
,
Minisini
R
,
Zito
C
,
Boccato
E
,
Boccato
E
,
Fimiani
F
,
Pirisi
M
,
Can apical ballooning cardiomyopathy and anterior STEMI be differentiated on beta 1 and beta 2 adrenergic receptors polymorphisms
.
Int J Cardiol
.
2015
;
199
:
189
.
6.
Isogai
T
,
Matsui
H
,
Tanaka
H
,
Fushimi
K
,
Yasunaga
H
.
Clinical characteristics of patients with Takotsubo syndrome diagnosed without coronary artery: a retrospective nationwide study
.
J Cardiol
.
2018
;
71
:
268
76
.
7.
Kurowski
V
,
Kaiser
A
,
von Hof
K
,
Killermann
DP
,
Mayer
B
,
Hartmann
F
,
Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis
.
Chest
.
2007
;
132
(
3
):
809
16
.
8.
Winham
DM
,
Jones
KM
.
Knowledge of young African American adults about heart disease: a cross-sectional survey
.
BMC Public Health
.
2011
;
11
:
248
. .
9.
Yancy
CW
.
Heart failure in African Americans
.
Am J Cardiol
.
2005
;
96
(
7b
):
3i
12i
. .
10.
Liburd
LC
,
Jack
L
 Jr
,
Williams
S
,
Tucker
P
.
Intervening on the social determinants of cardiovascular disease and diabetes
.
Am J Prev Med
.
2005
;
29
(
5 Suppl 1
):
18
24
. .
11.
Cohn
JN
,
Archibald
DG
,
Ziesche
S
,
Franciosa
JA
,
Harston
WE
,
Tristani
FE
,
Effect of vasodilator therapy on mortality in chronic congestive heart failure
.
N Eng J Med
.
1986
;
314
(
24
):
1547
52
.
12.
Kobasa
SC
.
Stressful life events, personality, and health: an inquiry into hardiness
.
J Pers Soc Psychol
.
1979
;
37
(
1
):
1
11
. .
13.
Kobasa
SC
,
Maddi
SR
,
Kahn
S
.
Hardiness and health: a prospective study
.
J Pers Soc Psychol
.
1982
;
42
(
1
):
168
77
. .
14.
Kessler
RC
,
Cleary
PD
.
Social class and psychological distress
.
Am Sociol Rev
.
1980
;
45
(
3
):
463
78
. .
15.
Dohrenwend
BP
,
Levav
I
,
Shrout
PE
,
Schwartz
S
,
Naveh
G
,
Link
BG
,
Socioeconomic status and psychiatric disorders: the causation-selection issue
.
Science
.
1992
;
255
(
5047
):
946
52
.
16.
Mirowsky
J
 2nd
,
Ross
CE
.
Minority status, ethnic culture, and distress: a comparison of Blacks, Whites, Mexicans, and Mexican Americans
.
Ajs
.
1980
;
86
(
3
):
479
95
. .
17.
Connor
KM
,
Davidson
JR
.
Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC)
.
Depress Anxiety
.
2003
;
18
(
2
):
76
82
. .
18.
Chen
E
,
Miller
GE
.
Socioeconomic status and health: mediating and moderating factors
.
Annu Rev Clin Psychol
.
2013
;
9
:
723
49
. .
19.
Saban
KL
,
Tell
D
,
Janusek
L
.
Resilience in African American women at risk for cardiovascular disease: an Exploratory Study
.
J Urban Health
.
2019
;
96
(
Suppl 1
):
44
9
. .
20.
Nielsen
NR
,
Kristensen
TS
,
Schnohr
P
,
Grønbaek
M
.
Perceived stress and cause-specific mortality among men and women: results from a prospective cohort study
.
Am J Epidemiol
.
2008
;
168
(
5
):
481
6
; discussion 92–6. .
21.
Kurnik
D
,
Friedman
EA
,
Muszkat
M
,
Sofowora
GG
,
Xie
HG
,
Dupont
WD
,
Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses
.
Pharmacogenet Genomics
.
2008
;
18
(
9
):
743
50
.
22.
Williams
D
,
Lawler
KA
.
Stress and illness in low-income women: the roles of hardiness, John Henryism, and race
.
Women Health
.
2001
;
32
(
4
):
61
75
. .
23.
Cusma-Piccione
M
,
Longobardo
L
,
Oteri
A
,
Manganaro
R
,
Di Bella
G
,
Carerj
S
,
Takatsubo cardiomyopathy: queries of the current era
.
J Cardiovasc Med
.
2018
;
19
:
624
32
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.